Melika mirghaffari | Tissue engineering | Best Researcher Award

Published on by Global Academic Awards

Ms. Melika mirghaffari | Tissue engineering | Best Researcher Award

student at Department of biomedical engineering, Science and research branch , islamic azad university, Tehran iran.

Melika Mirghaffari 🇮🇷 is a Biomedical Engineering student at Islamic Azad University, Science and Research Branch, Tehran (2020–2025). Her expertise includes biomedical materials, tissue engineering, and piezoelectric scaffolds 🧬. She has co-authored several research articles on bone and skin tissue regeneration 🦴 and nanofibrous scaffolds. Melika is a Research Assistant at ZhinoGene Research Services Co. and a Gamma Camera SPECT Technician Assistant at Sana Nuclear Medicine Center. Proficient in Python, AI, Biorender, and lab techniques, she is fluent in Persian, Azerbaijani, and English 🌍. Her interests include painting, mountaineering, and horseback riding 🎨🏔️.

 

Publication Profile

Orcid

🎓 Education Background

Melika Mirghaffari is currently pursuing a Bachelor of Science in Biomedical Engineering (2020–2025) at Islamic Azad University, Science and Research Branch, Tehran 🏛️. She previously obtained a High School Diploma in Mathematics and Physics (2019–2020) from Farzanegan 6 High School, Tehran 📐. Before that, she studied Natural Sciences at Farzanegan 6 High School, Tehran (2018–2019) and Farzanegan High School, Marand (2017–2018) 🔬. Her strong academic foundation in science and engineering has fueled her passion for biomedical research, focusing on tissue engineering and regenerative medicine 🧬.

 

🦴 Research Focus

Melika Mirghaffari specializes in biomedical engineering, focusing on tissue engineering, regenerative medicine, and biomaterials 🧬. Her research explores electro-spun piezoelectric PLLA smart composites for bone fracture healing, leveraging biodegradable scaffolds to enhance tissue regeneration 🦴🔬. She investigates piezoelectric nanomaterials, 3D-printed scaffolds, and self-powered electrical stimulation for bone and skin tissue repair ⚡. Her work integrates biomechanics, material science, and medical imaging, contributing to next-generation regenerative therapies. Her studies aim to advance biodegradable and biocompatible implants for orthopedic and soft tissue engineering, promoting faster recovery and improved patient outcomes 🏥.

 

Publication Top Notes

  • “Electro-spun Piezoelectric PLLA Smart Composites as a Scaffold on Bone Fracture: A Review” – Regenerative Therapy (🗓️ 2025) | 📑
  • “Enhancing Skin Tissue Regeneration: Ultrasound-Activated Piezoelectric PLLA Scaffolds for Self-Powered Electrical Stimulation” – (Revised, 2025) | 📑
  • “Polycaprolactone/Barium Titanate 3D-Printed Scaffolds: Enhancing Bone Regeneration through Biodegradable Piezoelectric Composite Structures – A Review” – IMAT (🗓️ 2024) | 📑
  • “Alginate–PVA Based Electrospun Piezoelectric Nanofibrous Scaffolds with BaTiO3 in Tissue Engineering: A Review” – (In preparation) | 📑
  • “Advances in Hydrophilic Coating Technologies for Angiography Guide Wires: Implications for Enhanced Performance” – (In preparation) | 📑

 

Erica Pietroluongo | Medicine | Young Scientist Award

Published on by Global Academic Awards

Dr. Erica Pietroluongo | Medicine | Young Scientist Award

Dr. Erica Pietroluongo, University of Naples Federico II, Italy

👩‍⚕️ Dr. Erica Pietroluongo is a dedicated oncologist and researcher based in Naples, Italy. With an MD from the University of Naples Federico II and ongoing PhD studies in Advanced Biomedical and Surgical Therapies, she specializes in medical oncology, particularly in rare tumors. Dr. Pietroluongo is actively involved in various professional societies, including the American Society of Clinical Oncology and the International Thymic Malignancy Working Group. Her research focuses on improving treatment personalization in breast cancer and investigating bioumoral determinants in SARS-Cov-2-infected patients with thymic epithelial tumors. She also contributes to teaching and training future medical professionals.

Publication Profile:

Scopus

Orcid

Education:

📚 Dr. Erica Pietroluongo pursued her passion for medicine at the University of Naples Federico II, where she earned her MD in Medicine. With a strong foundation in healthcare, she embarked on a journey of continuous learning, currently immersing herself in the realm of research as a PhD student in Advanced Biomedical and Surgical Therapies. Under the guidance of Prof. F Pane at the Department of Clinical Medicine and Surgery, University of Naples Federico II, she delves into cutting-edge studies. 🎓 Committed to advancing medical knowledge, Dr. Pietroluongo’s dual roles as a physician and researcher epitomize her dedication to enhancing patient care and outcomes.

Teaching and Training:

📝 Dr. Erica Pietroluongo is deeply committed to advancing her skills in clinical research and teaching methodologies. In April 2023, she participated in a Medical Writing Course organized by the Italian Society of Surgery in Campobasso, in collaboration with prestigious institutions like Springer Nature and the University of Naples Federico II. This course equipped her with essential writing skills vital for disseminating research findings effectively. Moreover, in June 2023, she further honed her expertise as an “Expert in Evaluation and Facilitation of Regional Oncology Networks” through a program facilitated by AGENAS, the National Agency for Health Regional Services. 🌟 These training initiatives underscore Dr. Pietroluongo’s commitment to enhancing her capabilities and contributing to the advancement of healthcare practices.

Research Focus:

🔍 Dr. Erica Pietroluongo’s research focus primarily revolves around two key areas: thymic epithelial tumors and breast cancer. In her studies on thymic epithelial tumors, she explores the impact of SARS-Cov-2 mRNA vaccines on patients’ immune responses and seroconversion. Additionally, she investigates the potential diagnostic role of miRNAs in breast cancer, particularly miRNA-27a and miRNA-128, packaged in extracellular vesicles. Her work not only sheds light on the immunological responses to COVID-19 vaccines in cancer patients but also aims to identify novel biomarkers for improved diagnosis and prognosis in breast cancer. Dr. Pietroluongo’s research contributes significantly to both oncology and immunology fields. 🎯

Publication Top Notes:

Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors

miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer

Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors